Jonathan Fintzi

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Topics

Placebo Controlled

Coronavirus Disease

Top Venues

Open forum infectious diseases

Statistics in medicine

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, Mahomed-Yunus Moosa, Corri B Levine, Hana M El Sahly, Susan L F McLellan, Constance A Benson, Christina A Rostad, Anuradha Ganesan, Nikhil Huprikar, Maria G Frank, Richard A Mularski, Robert L Atmar, Pauline K Park, William R Short, John H Beigel, Aneesh K Mehta, Daniel A Sweeney
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2. Open forum infectious diseases 9 (7) (2022)
Jonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, Nikhil A Huprikar, Anuradha Ganesan, Maria G Frank, Susan L F McLellan, Lori E Dodd, Pablo Tebas, Aneesh K Mehta
Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Dean A Follmann, Jonathan Fintzi, Michael P Fay, Holly E Janes, Lindsey R Baden, Hana M El Sahly, Thomas R Fleming, Devan V Mehrotra, Lindsay N Carpp, Michal Juraska, David C Benkeser, Deborah J Donnell, Youyi Fong, Shu Han, Ian Hirsch, Ying Huang, Yunda Huang, Ollivier Hyrien, Alex Luedtke, Marco Carone, Martha C Nason, An Vandebosch, Honghong Zhou, Iksung Cho, Erin Gabriel, James G Kublin, Myron S Cohen, Lawrence Corey, Peter B Gilbert, Kathleen M Neuzil
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated. Annals of internal medicine 174 (8) (2021)
Jonathan Fintzi, Jon Wakefield, Volodymyr M Minin
A linear noise approximation for stochastic epidemic models fit to partially observed incidence counts. Biometrics (2021)
Carrie Mae Long, Paul A Beare, Diane C Cockrell, Jonathan Fintzi, Mahelat Tesfamariam, Carl I Shaia, Robert A Heinzen
Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity. NPJ vaccines 6 (1) (2021)
Kizzmekia S Corbett-Helaire, Martha C Nason, Britta Flach, Matthew Gagne, Sarah O'Connell, Timothy S Johnston, Shruti N Shah, Venkata-Viswanadh Edara, Katharine A Floyd, Lilin Lai, Charlene McDanal, Joseph R Francica, Barbara Flynn, Kai Wu, Angela Choi, Matthew Koch, Olubukola M Abiona, Anne P Werner, Juan I Moliva, Shayne F Andrew, Mitzi M Donaldson, Jonathan Fintzi, Dillon R Flebbe, Evan Lamb, Amy T Noe, Saule T Nurmukhambetova, Samantha J Provost, Anthony Cook, Alan Dodson, Andrew Faudree, Jack Greenhouse, Swagata Kar, Laurent Pessiant, Maciel Porto, Katelyn Steingrebe, Daniel Valentin, Serge Zouantcha, Kevin W Bock, Mahnaz Minai, Bianca M Nagata, Renee Van De Wetering, Seyhan Boyoglu-Barnum, Kwanyee Leung, Wei Shi, Eun Sung Yang, Yi Zhang, John-Paul M Todd, Lingshu Wang, Gabriela S Alvarado, Hanne A Elyard, Kathryn E Foulds, Darin K Edwards, John R Mascola, Ian N Moore, Mark G Lewis, Andrea Carfi, David C Montefiori, Mehul S Suthar, Adrian B McDermott, Mario Roederer, Nancy J Sullivan, Daniel C Douek, Barney S Graham, Robert A Seder
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. Science (New York, N.Y.) 373 (6561) (2021)
Jonathan Fintzi, Dean A Follmann
Assessing vaccine durability in randomized trials following placebo crossover. Statistics in medicine 40 (27) (2021)
Christopher F Bosio, Clayton O Jarrett, Dana P Scott, Jonathan Fintzi, B Joseph Hinnebusch
Comparison of the transmission efficiency and plague progression dynamics associated with two mechanisms by which fleas transmit Yersinia pestis. PLoS pathogens 16 (12) (2020)